1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATORS
Compounds and pharmaceutical compositions of Formula (I) by blockade of the CB1 receptors via an inverse agonism mechanism which are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment wit...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SCHAUS, JOHN MEHNERT KRUSHINSKI, JOSEPH HERMAN JUNIOR TUPPER, DAVID EDWARD KEDING, STACY JO HU, JINGDAN COFFEY, DAVID SCOTT |
| description | Compounds and pharmaceutical compositions of Formula (I) by blockade of the CB1 receptors via an inverse agonism mechanism which are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment with antipsychotics and have increased bioavailability. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2667372C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2667372C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2667372C3</originalsourceid><addsrcrecordid>eNrjZAg01DHVdfEM8HD1i_TRNdZ1cvWLivRx9PX089eFSHlEugT5B0QGBfn7eLp4-uka6fr7uSo4Bis4OxkqBLk6uwaE-Acp-Pq7hPo4AlnBPAysaYk5xam8UJqbQd7NNcTZQze1ID8-tbggMTk1L7Uk3tnRyMzM3NjcyNmYsAoAoacuAg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATORS</title><source>esp@cenet</source><creator>SCHAUS, JOHN MEHNERT ; KRUSHINSKI, JOSEPH HERMAN JUNIOR ; TUPPER, DAVID EDWARD ; KEDING, STACY JO ; HU, JINGDAN ; COFFEY, DAVID SCOTT</creator><creatorcontrib>SCHAUS, JOHN MEHNERT ; KRUSHINSKI, JOSEPH HERMAN JUNIOR ; TUPPER, DAVID EDWARD ; KEDING, STACY JO ; HU, JINGDAN ; COFFEY, DAVID SCOTT</creatorcontrib><description>Compounds and pharmaceutical compositions of Formula (I) by blockade of the CB1 receptors via an inverse agonism mechanism which are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment with antipsychotics and have increased bioavailability.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2013</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130903&DB=EPODOC&CC=CA&NR=2667372C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130903&DB=EPODOC&CC=CA&NR=2667372C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>KRUSHINSKI, JOSEPH HERMAN JUNIOR</creatorcontrib><creatorcontrib>TUPPER, DAVID EDWARD</creatorcontrib><creatorcontrib>KEDING, STACY JO</creatorcontrib><creatorcontrib>HU, JINGDAN</creatorcontrib><creatorcontrib>COFFEY, DAVID SCOTT</creatorcontrib><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATORS</title><description>Compounds and pharmaceutical compositions of Formula (I) by blockade of the CB1 receptors via an inverse agonism mechanism which are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment with antipsychotics and have increased bioavailability.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2013</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAg01DHVdfEM8HD1i_TRNdZ1cvWLivRx9PX089eFSHlEugT5B0QGBfn7eLp4-uka6fr7uSo4Bis4OxkqBLk6uwaE-Acp-Pq7hPo4AlnBPAysaYk5xam8UJqbQd7NNcTZQze1ID8-tbggMTk1L7Uk3tnRyMzM3NjcyNmYsAoAoacuAg</recordid><startdate>20130903</startdate><enddate>20130903</enddate><creator>SCHAUS, JOHN MEHNERT</creator><creator>KRUSHINSKI, JOSEPH HERMAN JUNIOR</creator><creator>TUPPER, DAVID EDWARD</creator><creator>KEDING, STACY JO</creator><creator>HU, JINGDAN</creator><creator>COFFEY, DAVID SCOTT</creator><scope>EVB</scope></search><sort><creationdate>20130903</creationdate><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATORS</title><author>SCHAUS, JOHN MEHNERT ; KRUSHINSKI, JOSEPH HERMAN JUNIOR ; TUPPER, DAVID EDWARD ; KEDING, STACY JO ; HU, JINGDAN ; COFFEY, DAVID SCOTT</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2667372C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2013</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SCHAUS, JOHN MEHNERT</creatorcontrib><creatorcontrib>KRUSHINSKI, JOSEPH HERMAN JUNIOR</creatorcontrib><creatorcontrib>TUPPER, DAVID EDWARD</creatorcontrib><creatorcontrib>KEDING, STACY JO</creatorcontrib><creatorcontrib>HU, JINGDAN</creatorcontrib><creatorcontrib>COFFEY, DAVID SCOTT</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SCHAUS, JOHN MEHNERT</au><au>KRUSHINSKI, JOSEPH HERMAN JUNIOR</au><au>TUPPER, DAVID EDWARD</au><au>KEDING, STACY JO</au><au>HU, JINGDAN</au><au>COFFEY, DAVID SCOTT</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATORS</title><date>2013-09-03</date><risdate>2013</risdate><abstract>Compounds and pharmaceutical compositions of Formula (I) by blockade of the CB1 receptors via an inverse agonism mechanism which are useful for reducing body weight in mammals, cognitive impairment associated with schizophrenia, mitigating treatment emergent weight gain observed during treatment with antipsychotics and have increased bioavailability.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA2667372C |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 1,5-DIPHENYL-3-BENZYLAMINO-1,5-DIHYDROPYRROLIDIN-2-ONE AS CB1 RECEPTOR MODULATORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A58%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SCHAUS,%20JOHN%20MEHNERT&rft.date=2013-09-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2667372C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |